ACD/Labs
Advanced Chemistry Development (ACD/Labs) develops and commercializes informatics solutions for chemical, biochemical and pharmaceutical research and development. Their expertise lies in vendor-agnostic spectroscopic and chromatographic data processing and prediction, physicochemical and absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) property prediction, analytical knowledge management, interactive reporting and integrating analytical data with chemical structures to help protect and leverage valuable research knowledge.
Latest Content
AI and ML in the Modern Laboratory: High-Throughput Experimentation and Beyond
ACD/Labs Announces Version 2025 of Software on Its Spectrus® & Percepta® Platforms
Revvity To Acquire ACD/Labs To Expand Its Signals Software Capabilities
ACD/Labs Announces Katalyst D2D® Software Release With Expanded Capabilities for Accelerated Pharmaceutical Development
ACD/Labs and Covestro Announce Collaboration Delivering AI-Supported Solvent Selection at PhysChem Forum 2025
Redefining Pharmaceutical R&D Through AI and the Digitalized Physical DMTA Cycle
Faster, More Confident Small Molecule Structure Verification in Pharmaceutical R&D
ACD/Labs Releases State-of-the-Industry Report Highlighting Trends in Chemical Structure Elucidation & Verification
ACD/Labs Launches Version 2024 of Spectrus Software for Digitalized, Data-Driven R&D